Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: CK-2017357; Other: Placebo tablets; Drug: Riluzole
Sponsor: Cytokinetics
Completed - verified January 2017
Interventions: Drug: CK-2017357; Other: Placebo tablets; Drug: Riluzole
Sponsor: Cytokinetics
Completed - verified January 2017